These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 2569930

  • 1. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
    Yusa K, Tsuruo T.
    Cancer Res; 1989 Sep 15; 49(18):5002-6. PubMed ID: 2569930
    [Abstract] [Full Text] [Related]

  • 2. Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement.
    Naito M, Tsuruo T.
    Cancer Res; 1989 Mar 15; 49(6):1452-5. PubMed ID: 2924298
    [Abstract] [Full Text] [Related]

  • 3. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
    Akiyama S, Yoshimura A, Kikuchi H, Sumizawa T, Kuwano M, Tahara Y.
    Mol Pharmacol; 1989 Nov 15; 36(5):730-5. PubMed ID: 2573823
    [Abstract] [Full Text] [Related]

  • 4. Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cells.
    Hamada H, Okochi E, Watanabe M, Oh-hara T, Sugimoto Y, Kawabata H, Tsuruo T.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7082-7. PubMed ID: 2903793
    [Abstract] [Full Text] [Related]

  • 5. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
    Tsuruo T.
    Prog Clin Biol Res; 1986 Dec 15; 223():203-16. PubMed ID: 3468516
    [Abstract] [Full Text] [Related]

  • 6. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
    Watanabe M, Komeshima N, Naito M, Isoe T, Otake N, Tsuruo T.
    Cancer Res; 1991 Jan 01; 51(1):157-61. PubMed ID: 1988080
    [Abstract] [Full Text] [Related]

  • 7. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate.
    Arkin H, Ohnuma T, Kamen BA, Holland JF, Vallabhajosula S.
    Cancer Res; 1989 Dec 01; 49(23):6556-61. PubMed ID: 2573416
    [Abstract] [Full Text] [Related]

  • 8. Properties of verapamil-hypersensitive multidrug-resistant Chinese hamster ovary cells.
    Warr JR, Anderson M, Fergusson J.
    Cancer Res; 1988 Aug 15; 48(16):4477-83. PubMed ID: 2899455
    [Abstract] [Full Text] [Related]

  • 9. Lack of reversal of daunorubicin resistance in HL60/AR cells by cyclosporin A.
    Gollapudi S, Gupta S.
    Anticancer Res; 1992 Aug 15; 12(6B):2127-32. PubMed ID: 1363515
    [Abstract] [Full Text] [Related]

  • 10. Purification of the Mr 22,000 calcium-binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies.
    Hamada H, Okochi E, Oh-hara T, Tsuruo T.
    Cancer Res; 1988 Jun 01; 48(11):3173-8. PubMed ID: 3365700
    [Abstract] [Full Text] [Related]

  • 11. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T.
    Gan To Kagaku Ryoho; 1984 Mar 01; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [Abstract] [Full Text] [Related]

  • 12. Binding of an optically pure photoaffinity analogue of verapamil, LU-49888, to P-glycoprotein from multidrug-resistant human leukemic cell lines.
    Qian XD, Beck WT.
    Cancer Res; 1990 Feb 15; 50(4):1132-7. PubMed ID: 1967551
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
    Beck WT, Cirtain MC, Danks MK, Felsted RL, Safa AR, Wolverton JS, Suttle DP, Trent JM.
    Cancer Res; 1987 Oct 15; 47(20):5455-60. PubMed ID: 2888532
    [Abstract] [Full Text] [Related]

  • 14. Characterization of a K562 multidrug-resistant cell line.
    Yanovich S, Hall RE, Gewirtz DA.
    Cancer Res; 1989 Aug 15; 49(16):4499-503. PubMed ID: 2568171
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of multidrug resistance in HL60 cells: evidence that a surface membrane protein distinct from P-glycoprotein contributes to reduced cellular accumulation of drug.
    McGrath T, Center MS.
    Cancer Res; 1988 Jul 15; 48(14):3959-63. PubMed ID: 2898287
    [Abstract] [Full Text] [Related]

  • 16. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Xu HB, Li L, Liu GQ.
    Pharmazie; 2009 Oct 15; 64(10):660-5. PubMed ID: 19947169
    [Abstract] [Full Text] [Related]

  • 17. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers.
    Safa AR, Glover CJ, Sewell JL, Meyers MB, Biedler JL, Felsted RL.
    J Biol Chem; 1987 Jun 05; 262(16):7884-8. PubMed ID: 3034908
    [Abstract] [Full Text] [Related]

  • 18. Reversal of multidrug resistance by verapamil and modulation by alpha 1-acid glycoprotein in wild-type and multidrug-resistant Chinese hamster ovary cell lines.
    Chatterjee M, Robson CN, Harris AL.
    Cancer Res; 1990 May 01; 50(9):2818-22. PubMed ID: 1970277
    [Abstract] [Full Text] [Related]

  • 19. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha.
    Licht T, Lübbert M, Martens C, Bross KJ, Fiebig HH, Mertelsmann R, Herrmann F.
    Cytokines Mol Ther; 1995 Jun 01; 1(2):123-32. PubMed ID: 9384669
    [Abstract] [Full Text] [Related]

  • 20. Cross-resistance of human multidrug-resistant cells to mitomycin C.
    Yusa K, Sato W, Yamazaki A, Tsukahara S, Tsuruo T.
    Anticancer Res; 1991 Jun 01; 11(3):1301-4. PubMed ID: 1909515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.